NFKB1 and inflammatory bowel disease: NF-κB is a well-known modulator of tumour necrosis factor, which H. erinaceus has demonstrated to down-regulate in combination with the other components of Enteroflegin® in human inflammatory bowel disease ex vivo models [13].